Lindy Biosciences
Latest round
- Series A
Last raised
- Apr 2019
Total raised
- $1.6M
Investors
- 5
About Lindy Biosciences
Founded in 2017 and headquartered in the United States, Lindy Biosciences focuses on transforming the administration of biotherapeutics.Lindy Biosciences specializes in innovative biotherapeutics drug delivery solutions, with a primary focus on its proprietary Microglassification™ technology. This core product enables the self-administration of medications in home settings, aiming to alleviate the burdens associated with traditional intravenous infusions, which are commonly administered in acute care environments. By transforming the administration of antibody therapeutics, Lindy seeks to enhance patient comfort and autonomy, ultimately improving the quality of life for individuals managing chronic illnesses.Lindy Biosciences operates within a business model that emphasizes partnerships and collaborations with industry stakeholders involved in biotherapeutic development. The revenue streams are generated through strategic partnerships where clients utilize the Microglassification platform to enhance their own drug delivery products. This collaborative approach includes agreements structured around joint development initiatives, where revenue is accrued based on the successful integration of Lindy’s technology into clients’ offerings. The company’s flagship Microglassification technology serves as a significant focal point for these transactions, as clients seek to leverage its capabilities to improve their therapeutic delivery methods. Additionally, the company is targeting expansion into key markets across North America and Europe, with an aggressive timeline to establish a broader footprint in these regions by the end of 2023. These initiatives will be crucial in fulfilling the increasing demands for innovative drug delivery solutions in the biotherapeutics sector.
Who invested in Lindy Biosciences
5 investors across 1 round
See all investors in Lindy Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 22, 2019
Amount
$1.6M
Investors
Questions about Lindy Biosciences
Who invested in Lindy Biosciences?
Lindy Biosciences has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lindy Biosciences raised?
Lindy Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Lindy Biosciences last raise money?
Lindy Biosciences's most recent round on record is a Series A, in Apr 2019.
What does Lindy Biosciences do?
Founded in 2017 and headquartered in the United States, Lindy Biosciences focuses on transforming the administration of biotherapeutics.
Where is Lindy Biosciences headquartered?
Lindy Biosciences is headquartered in US.
Which VCs invest in companies like Lindy Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lindy Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Lindy Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.